Lifevantage (LFVN) Misses Q2 EPS by 1c; Guides FY14 EPS, Revs

Lifevantage (NASDAQ: LFVN) reported Q2 EPS of $0.02, $0.01 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $56 million versus the consensus estimate of $54.95 million.

Lifevantage sees FY2014 EPS of $0.14-$0.16, versus the consensus of $0.11. Lifevantage sees FY2014 revenue of $225-235 million, versus the consensus of $212.9 million.

For earnings history and earnings-related data on Lifevantage (LFVN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Worried the AI trade has gone too far? Evercore likes these 4 stocks
• NVE Corporation names new CEO and expands board to seven members